Global Somatostatin Analogs Market by Major Players, Product Type, by Application, and by Region (North America, Europe, China, Japan, South Korea, India)Forecast from 2020 to 2026

Published On: May 2020

Format: PDF

Publisher: Calibre Research

Pages: 160

Report ID: 11051

The Global Somatostatin Analogs market size is expected to increased from USD xx million in last year to USD xx million by 2026 at a CAGR of xx% during the projected timespan of 2020-2026. According to the study, the worldwide Somatostatin Analogs market is fragmented into essential industry players, applications, regions and product types.

Overview: Global Somatostatin Analogs market

Somatostatin analogs are considered to be the drugs that halt huge hormonal secretion in the human body. Neuroendocrine Tumors(NETs) as well as Acromegaly, a rare hormonal disease, which are most common signs treated along with somatostatin analogs. While, some other tumors treated with somatostatin analogs are said to be glucagonomas, VIPomas, GH-secreting tumors as well as carcinoid tumors. They are also used to treat syndrome of Cushing.

Dynamics: Global Somatostatin Analogs market

The worldwide healthcare industry has been witnessing massive shifting improvements with involvement of digital technology as well as newer inventions in the form of devices and novel drugs. The aging, increasing world population and growing prevalence of chronic disease are major components impacting the Global Somatostatin Analogs market.

The aging population will require healthcare assistance in format or other. The Somatostatin Analogs market product as well as services demand is expected with gain in increasing healthcare requirements of this extravagant population and chronic disorder.

The research report on the Global Somatostatin Analogs market concentrates on insightful details on the important industry shaping distinct dynamics that are and will govern the Somatostatin Analogs market growth across the world.

Global Somatostatin Analogs market: Prime companies

  • Novartis AG
  • Sun Pharmaceutical Industries Ltd
  • Midatech Pharma PLC
  • Ipsen Pharma
  • Chiasma, Inc.
  • Peptron, Inc.
  • CRINETICS PHARMACEUTICALS
  • Dauntless Pharmaceuticals
  • Camurus AB
  • Teva Pharmaceuticals Inc.
  • Pfizer Inc.

By Product Types:

  • Octreotide
  • Lanreotide
  • Pasireotide

By Applications:

  • Acromegaly
  • Neuroendocrine Tumors (NETs)

Regional Outlook: Global Somatostatin Analogs market

North America is most emerging industry in the Somatostatin Analogs market which anticipated to contribute more than 52 percent of the revenue share. The large prevalence of NETs and acromegaly is assumed to be the major drivers that are accountable for region-wise growth of Global Somatostatin Analogs market.

The region of Asia-Pacific is evaluated to witness the biggest growth over the predicted timeframe. Rise in the diagnosis rate of NET in nations including Japan, South Korea and Japan merged with increasing per capita income is an extremely high impact influencing driver for the Global Somatostatin Analogs market.

By Regions:

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • South America
  • Brazil
  • Argentina


     

Somatostatin Analogs Market Overview

Product Overview and Scope of Somatostatin Analogs

Executive Summary

Classification of Somatostatin Analogs by Type

Global Somatostatin Analogs Market Revenue Comparison by Type (2020-2026)

Global Somatostatin Analogs Revenue Market Share by Type in 2019

Global Somatostatin Analogs Volume Market Share by Type in 2019

Type Segment

Octreotide

Lanreotide

Pasireotide

Application Outlook (Revenue, USD Million, 2015 - 2026)

Acromegaly

Neuroendocrine Tumors (NETs)

 

*

*Somatostatin Analogs Market Value

Somatostatin Analogs Market Volume

Classification of Somatostatin Analogs by Application

Global Somatostatin Analogs Market Revenue Comparison by Application (2020-2026)

Global Somatostatin Analogs Revenue Market Share by Application in 2019

Global Somatostatin Analogs Volume Market Share by Application in 2019

Global Somatostatin Analogs Market by Regions

Global Somatostatin Analogs Market Size (Million USD) and Volume Comparison by Regions (2020-2026)

North America (USA, Canada and Mexico) Somatostatin Analogs Status and Prospect (2014-2026)

Europe (Germany, France, UK, Russia and Italy) Somatostatin Analogs Status and Prospect (2014-2026)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Somatostatin Analogs Status and Prospect (2014-2026)

South America (Brazil, Argentina, Colombia) Somatostatin Analogs Status and Prospect (2014-2026)

Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Somatostatin Analogs Status and Prospect (2014-2026)

Global Market Size of Somatostatin Analogs (2014-2026)

Market Dynamics

Drivers

Restraints

Opportunities

Porter’s Five Forces Analysis

Porter’s Five Forces Analysis

Key Market Strategies

Key Market Strategies, 2019 (%)

Company Profiles

Novartis AG

Sun Pharmaceutical Industries Ltd

Midatech Pharma PLC

Ipsen Pharma

Chiasma, Inc.

Peptron, Inc.

CRINETICS PHARMACEUTICALS

Dauntless Pharmaceuticals

Camurus AB

Teva Pharmaceuticals Inc.

Pfizer Inc.

*Company Basic Information and Its Competitors

*Product Category

*Key Products

*Company Somatostatin Analogs Production and Revenue (2014-2018)

*Company Recent Developments

Main Business/Business Overview

Global Somatostatin Analogs Market Competition, by Players

Global Somatostatin Analogs Market Production, Revenue, and Share by Players (2014-2018)

Global Somatostatin Analogs Market Production and Share by Players (2014-2018)

Global Somatostatin Analogs Market Revenue and Share by Players (2014-2018)

Market Concentration Rate

Top 3 Somatostatin Analogs Players Market Share

Top 5 Somatostatin Analogs Players Market Share

Global Somatostatin Analogs Market Size by Regions

Global Somatostatin Analogs Market Volume, Revenue, and Market Share by Regions

Global Somatostatin Analogs Market Volume, By Region (2014-2026)

North America Somatostatin Analogs Market Volume, Revenue, and Growth Rate (2014-2019)

Europe Somatostatin Analogs Market Volume, Revenue, and Growth Rate (2014-2019)

Asia-Pacific Somatostatin Analogs Market Volume, Revenue, and Growth Rate (2014-2019)

South America Somatostatin Analogs Market Volume, Revenue, and Growth Rate (2014-2019)

Middle East & Africa Somatostatin Analogs Market Volume, Revenue, and Growth Rate (2014-2019)

North America Somatostatin Analogs Market Revenue by Countries

North America Somatostatin Analogs Market Revenue, by Countries (2014-2019)

North America Somatostatin Analogs Market Volume, by Countries (2014-2019)

USA Somatostatin Analogs Market Revenue and Growth Rate (2014-2019)

USA Somatostatin Analogs Market Volume and Growth Rate (2014-2019)

Canada Somatostatin Analogs Market Revenue and Growth Rate (2014-2019)

Canada Somatostatin Analogs Market Volume and Growth Rate (2014-2019)

Mexico Somatostatin Analogs Revenue and Growth Rate (2014-2019)

Mexico Somatostatin Analogs Market Volume and Growth Rate (2014-2019)

Europe Somatostatin Analogs Market Revenue by Countries

Europe Somatostatin Analogs Market Revenue, by Countries (2014-2019)

Europe Somatostatin Analogs Market Volume, by Countries (2014-2019)

Germany Somatostatin Analogs Market Revenue and Growth Rate (2014-2019)

Germany Somatostatin Analogs Market Volume and Growth Rate (2014-2019)

France Somatostatin Analogs Market Revenue and Growth Rate (2014-2019)

France Somatostatin Analogs Market Volume and Growth Rate (2014-2019)

UK Somatostatin Analogs Market Revenue and Growth Rate (2014-2019)

UK Somatostatin Analogs Market Volume and Growth Rate (2014-2019)

Italy Somatostatin Analogs Market Revenue and Growth Rate (2014-2019)

Italy Somatostatin Analogs Market Volume and Growth Rate (2014-2019)

Russia Somatostatin Analogs Market Revenue and Growth Rate (2014-2019)

Russia Somatostatin Analogs Market Volume and Growth Rate (2014-2019)

Asia-Pacific Somatostatin Analogs Revenue by Countries

Asia-Pacific Somatostatin Analogs Market Revenue, by Countries (2014-2019)

Asia-Pacific Somatostatin Analogs Market Volume, by Countries (2014-2019)

China Somatostatin Analogs Market Revenue and Growth Rate (2014-2019)

China Somatostatin Analogs Market Volume and Growth Rate (2014-2019)

Japan Somatostatin Analogs Market Revenue and Growth Rate (2014-2019)

Japan Somatostatin Analogs Market Volume and Growth Rate (2014-2019)

Korea Somatostatin Analogs Market Revenue and Growth Rate (2014-2019)

Korea Somatostatin Analogs Market Volume and Growth Rate (2014-2019)

India Somatostatin Analogs Market Revenue and Growth Rate (2014-2019)

India Somatostatin Analogs Market Volume and Growth Rate (2014-2019)

South America Somatostatin Analogs Revenue by Countries

South America Somatostatin Analogs Market Revenue, by Countries (2014-2019)

South America Somatostatin Analogs Market Volume, by Countries (2014-2019)

Brazil Somatostatin Analogs Market Revenue and Growth Rate (2014-2019)

Brazil Somatostatin Analogs Market Volume and Growth Rate (2014-2019)

Argentina Somatostatin Analogs Market Revenue and Growth Rate (2014-2019)

Argentina Somatostatin Analogs Market Volume and Growth Rate (2014-2019)

Middle East & Africa Revenue Somatostatin Analogs by Countries

Middle East & Africa Somatostatin Analogs Market Revenue by Countries (2014-2019)

Middle East & Africa Somatostatin Analogs Market Volume by Countries (2014-2019)

Saudi Arabia Somatostatin Analogs Market Revenue and Growth Rate (2014-2019)

Saudi Arabia Somatostatin Analogs Market Volume and Growth Rate (2014-2019)

UAE Somatostatin Analogs Revenue and Growth Rate (2014-2019)

UAE Somatostatin Analogs Market Volume and Growth Rate (2014-2019)

Egypt Somatostatin Analogs Market Revenue and Growth Rate (2014-2019)

Egypt Somatostatin Analogs Market Volume and Growth Rate (2014-2019)

South Africa Somatostatin Analogs Revenue and Growth Rate (2014-2019)

South Africa Somatostatin Analogs Market Volume and Growth Rate (2014-2019)

Global Somatostatin Analogs Market Segment by Type

Global Somatostatin Analogs Market Revenue and Market Share by Type (2014-2019)

Global Somatostatin Analogs Market Forecast by Type (2020-2026)

Type Segment

Octreotide

Lanreotide

Pasireotide

Application Outlook (Revenue, USD Million, 2015 - 2026)

Acromegaly

Neuroendocrine Tumors (NETs)

 

 

Somatostatin Analogs Market Revenue (2014-2026)

Somatostatin Analogs Market Volume (2014-2026)

Global Somatostatin Analogs Market Volume and Market Share by Type (2014-2019)

Global Somatostatin Analogs Market Forecast by Type (2020-2026)

Global Somatostatin Analogs Market Segment by Application

Global Somatostatin Analogs Market Revenue and Market Share by Application (2014-2019)

Global Somatostatin Analogs Market Forecast by Application (2020-2026)

Global Somatostatin Analogs Market Revenue Forecast by Regions (2020-2026)

North America Somatostatin Analogs Market Revenue Forecast (2020-2026)

Europe Somatostatin Analogs Market Revenue Forecast (2020-2026)

Asia-Pacific Somatostatin Analogs Market Revenue Forecast (2020-2026)

South America Somatostatin Analogs Market Revenue Forecast (2020-2026)

Middle East & Africa Somatostatin Analogs Market Revenue Forecast (2020-2026)

Global Somatostatin Analogs Market Volume Forecast by Regions (2020-2026)

North America Somatostatin Analogs Market Volume Forecast (2020-2026)

Europe Somatostatin Analogs Market Volume Forecast (2020-2026)

Asia-Pacific Somatostatin Analogs Market Volume Forecast (2020-2026)

South America Somatostatin Analogs Market Volume Forecast (2020-2026)

Middle East & Africa Somatostatin Analogs Market Volume Forecast (2020-2026)

Research Conclusion

Analyst View

Premium Market Insights

Appendix

Methodology

Primary Research

Research Methodology

Assumptions & Exclusions

Secondary data sources

Disclaimer